Endocyte, Inc. (ECYT)
(Delayed Data from NSDQ)
$23.99 USD
0.00 (0.00%)
Updated Dec 20, 2018 04:00 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
[ECYT]
Reports for Purchase
Showing records 1 - 20 ( 252 total )
Industry: Medical - Drugs
Industry: Medical - Drugs
Industry: Medical - Drugs
Industry: Medical - Drugs
Industry: Medical - Drugs
ValuEngine Detailed Valuation Report for ECYT
Provider: ValuEngine, Inc
Industry: Medical - Drugs
Industry: Medical - Drugs
Downgrading to NEUTRAL as Top Pick ECYT gets Acquired by Novartis
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Industry: Medical - Drugs
Industry: Medical - Drugs
HEALTHCARE - The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Industry: Medical - Drugs
Biotechnology -ESMO 2018 Abstract Roundup for Covered Companies
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Industry: Medical - Drugs
HEALTHCARE - The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Industry: Medical - Drugs
Industry: Medical - Drugs
Updated VISION Protocol to Include rPFS as Primary Endpoint
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Industry: Medical - Drugs
Industry: Medical - Drugs
Industry: Medical - Drugs
Industry: Medical - Drugs
Industry: Medical - Drugs
Xofigo Safety Concerns Should Strengthen 177Lu?s Competitive Positioning
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D